| Abstract | Radioiodine and thionamide treatment are the most frequently used treatment modalities for thyrotoxicosis in Europe and North America with surgery being reserved for selected cases. * In our clinic patients were offered all three modalities via simultaneous interview with an endocrinologist and a surgeon, with international risk benefit data for radioiodine and thionamide therapy, and local risk benefit data for total thyroidectomy provided. * When given the choice, at least 15% of patients opted for total thyroidectomy over the other modalities. * In our series of 100 consecutive surgical patients there was a 4% malignancy rate. * Total thyroidectomy should be offered equally, with radioiodine and thionamide treatment, as a first line treatment modality in the management of thyrotoxicosis. |
| Authors | R J A England, M B Kamath, A Jabreel, G Dunne, S L Atkin
(Affiliation: Departments of Otolaryngology Head and Neck Surgery and Endocrinology, Hull Royal Infirmary, UK. rjaeathome at aol.com)
|
| Journal | Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
(Clin Otolaryngol)
Vol. 31
Issue 2
Pg. 160-2
(Apr 2006)
ISSN: 1749-4478 England |
| PMID | 16620341
(Publication Type: Journal Article)
|
| Chemical References |
- Antithyroid Agents
- Iodine Radioisotopes
|
| Topics |
- Adolescent
- Adult
- Aged
- Antithyroid Agents
(therapeutic use)
- Female
- Humans
- Iodine Radioisotopes
(therapeutic use)
- Male
- Middle Aged
- Thyroidectomy
- Thyrotoxicosis
(surgery, therapy)
- Treatment Outcome
|
